High-Risk Pregnancies: Birth Defects in Women Over 35

Introduction

Having a baby is a dream that many families share. Women in particular are closely associated with the idea of having a child, though men are often equally excited — and nervous — when the time comes. However, there is a real danger in waiting too long to start a family. Whether the delay is driven by career concerns, finding the right partner, postponed marriage, or other factors, many women in today's society put off having children for a variety of understandable reasons. An unfortunate consequence of this pattern is that the risk of birth defects is significantly higher in children born to women over the age of 35.

This paper explores the specific reasons that birth defects are more common in pregnancies beyond that threshold. Even as the trend of women having children at older ages continues to grow, the complications that arise beyond a certain age are well-documented and statistically consistent. While women should absolutely have the freedom to have children if they wish and have the resources to do so, pregnancies after the age of 35 carry inherent risks whose causes and potential consequences deserve careful examination.

Literature Review

There are many directions one could take when reviewing the literature on this subject. One notable finding is that even though older fetuses are at higher risk of birth defects when the mother is over 35, many women in that age group actively avoid or delay the relevant diagnostic tests. While some women are opposed to abortion as a means of avoiding the birth of a child with special needs, the key principle is that any decision should be made with fully informed consent. Many women, however, avoid or postpone this due diligence — and this is not a new phenomenon. Although general risk assessments and non-invasive screening can be useful, there are more exhaustive and effective methods available (Dunn, 2003).

Another dimension that is real but less commonly discussed is the question of which populations to target for birth defect screening. Rather than simply casting a wide net based solely on age, some researchers argue that certain groups and cultures warrant greater scrutiny than others (Zhu et al., 2016). A more recent and high-profile risk factor has emerged with the Zika virus outbreak. Research has confirmed extremely serious risks of birth defects in women of any age who become infected with Zika. While it is unlikely that more common infections such as influenza or the common cold cause similar defects, the effects of bacterial and viral infections on pregnant women and their fetuses deserve increased attention in light of what Zika has revealed.

Even with age 35 serving as a recognized threshold, crossing into one's forties before having children carries even greater risk. Beyond that, a multiple-birth pregnancy — such as twins — after the age of 40 poses substantial additional dangers. Most women do not seek multiple births, but in vitro fertilization and other fertility treatments often involve implanting multiple embryos to increase the likelihood of success. As a result, multiple births are not uncommon outcomes. When this occurs, the perinatal risks are considerable even under the best circumstances. Underlying chronic health conditions such as hypertension and diabetes amplify these risks further (Grabowska et al., 2012).

It is also worth noting that some women over 35 become pregnant unexpectedly. Even when a pregnancy is unplanned, the outcomes in terms of mortality, economic impact, and health statistics are still recorded in the broader data. By default, the amount of prenatal care received will be lower until the pregnancy is discovered, which can take several weeks compared to someone actively monitoring their reproductive health. Unplanned pregnancies at any age tend to skew overall datasets, and this must be considered when analyzing how and when birth defects are detected and what actions are taken upon detection. Although the data is from more than a generation ago, one study found that the mortality rate for women with unexpected pregnancies was triple the average (Darbois & Boulanger, 1990).

Despite the common narrative about the risks of pregnancy after 35 or 40, some researchers have disputed these concerns — including a journal article published as far back as 1987 that argued pregnancies over 40 were no longer "high risk" (Darbois et al., 1987). However, knowledge accumulated since then has substantially undermined that claim. For example, a study spanning 2010 to 2014 that examined the effects of influenza vaccination during pregnancy found that even this routine intervention was associated with a range of adverse outcomes including birth defects, spontaneous abortion, preterm delivery, and low birth weight for gestational age. Differences in defect rates were clearly linked to whether the vaccine was administered, illustrating how seemingly minor factors can meaningfully affect outcomes (Chambers et al., 2016).

Similarly, it is common practice for people in close contact with a newborn to receive the Tdap vaccine — a combination shot protecting against tetanus, pertussis (whooping cough), and diphtheria. Women who intend to become pregnant should receive this vaccine before conception rather than during pregnancy. As with the influenza vaccine, poorly timed administration raises the risk of birth defects. While vaccine-related risks are not age-specific in isolation, they are amplified in older mothers, much as certain medications amplify other substances' effects in the body. The risk of birth defects from aggravating factors — whether vaccines, medications, or infections — is measurably greater in women of advanced maternal age (DeSilva et al., 2016).

Environmental causes of birth defects represent another, less visible concern. Unlike Zika — which is widely known and closely monitored — environmental threats are often invisible or dismissed. Before the 1970s, asbestos is a well-known example of a hazardous material that was in widespread use without recognition of its dangers. A more contemporary concern involves air pollutants. If a pregnant woman is exposed to substances such as benzene or fine particulate matter (PM2.5), the consequences can be severe, including spina bifida and cleft palate. This type of exposure was documented in Florida in a study published by Tanner et al. (2015). As with other risk factors, the harm caused by such environmental exposures is compounded when the mother is over 35.

Even something as commonplace as a decongestant warrants attention. A 2013 study found that while only three specific birth defects showed increased prevalence with decongestant use, that number is still greater than zero and therefore clinically relevant. Furthermore, older women are generally more susceptible to illness and therefore more likely to use such medications, increasing both their exposure risk and the associated risk to the fetus (Yau et al., 2013). The same logic applies to chronic conditions like diabetes and hypertension, which tend to be more advanced and harder to manage in older individuals, including expectant mothers in their late 30s and beyond. Ideally, family planning would include lifestyle adjustments before conception to reduce risk to the fetus. When that is not possible, mitigation strategies should be implemented as soon as the full clinical picture is known. While improvements in chronic disease management will reduce this factor over time, it will never be entirely eliminated as a contributor to birth defect rates in this age group.

Conclusion

The overall findings of this research are likely to align with the general parameters outlined in this proposal. However, the details and specifics may well yield surprises. While the overall risk of birth defects may not be enough to deter every woman who wishes to have a child after 35, those women can and should be fully informed of the specific risks involved, the birth defects that are most likely to occur, how to screen for them, when to do so, and how best to reduce their likelihood. This level of preparation and informed consent is essential so that women can move forward in their reproductive decisions with clarity and confidence rather than uncertainty or regret.

References

Chambers, C. D., Johnson, D. L., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., & Jones, K. L. (2016). Safety of the 2010–11, 2011–12, 2012–13, and 2013–14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS. Vaccine, 34(37), 4443–4449. doi:10.1016/j.vaccine.2016.06.054

Darbois, Y., & Boulanger, M. C. (1990). [Are unexpected pregnancies over age 40 at high risk?]. Revue Française de Gynécologie et d'Obstétrique, 85(3), 158–160.

Darbois, Y., Lefebvre, G., Vauthier, D., & Camus, M. (1987). [Pregnancy over the age of 40 is no longer a high-risk pregnancy]. La Revue du Praticien, 37(9), 481–487.

DeSilva, M., Vazquez-Benitez, G., Nordin, J. D., Lipkind, H. S., Romitti, P. A., Destefano, F., & Kharbanda, E. O. (2016). Tdap vaccination during pregnancy and microcephaly and other structural birth defects in offspring. JAMA, 316(17), 1823–1825. doi:10.1001/jama.2016.14432

Dunn, A. (2003, March 13). Older women avoid birth defect tests. The Age (Melbourne), p. 6.

Grabowska, K., Metcalfe, A., Pastuck, M., Tough, S., & Johnson, J. (2012). OP30.01: The perinatal risks of twin pregnancy in women over the age of 40. Ultrasound in Obstetrics & Gynecology, 40, 145–146. doi:10.1002/uog.11680

Oakley, G. J. (2012). Failing to prevent birth defects caused by maternal diabetes mellitus. American Journal of Obstetrics and Gynecology, 206(3), 179–180. doi:10.1016/j.ajog.2011.12.019

Rasmussen, S. A., Jamieson, D. J., Honein, M. A., & Petersen, L. R. (2016). Zika virus and birth defects — reviewing the evidence for causality. The New England Journal of Medicine, 374(20), 1981–1987. doi:10.1056/NEJMsr1604338

Tanner, J. P., Salemi, J. L., Stuart, A. L., Yu, H., Jordan, M. M., Duclos, C., & Kirby, R. S. (2015). Associations between exposure to ambient benzene and PM2.5 during pregnancy and the risk of selected birth defects in offspring. Environmental Research, 142, 345–353. doi:10.1016/j.envres.2015.07.006

Yau, W., Mitchell, A. A., Lin, K. J., Werler, M. M., & Hernandez-Diaz, S. (2013). Use of decongestants during pregnancy and the risk of birth defects. American Journal of Epidemiology, 178(2), 198–208.

Zhu, Z., Cheng, Y., Yang, W., Li, D., Yang, X., Liu, D., & Zeng, L. (2016). Who should be targeted for the prevention of birth defects? A latent class analysis based on a large, population-based, cross-sectional study in Shaanxi Province, Western China. PLOS ONE, 11(5), 1–16. doi:10.1371/journal.pone.0155587